-
Hot Watch List: Auspex Pharmaceuticals (NASDAQ:ASPX), McDermott International Inc. (NYSE:MDR), Ford Motor Company (NYSE:F), World Wrestling Entertainment (NYSE:WWE), Aerohive Networks (NYSE:HIVE)
On Tuesday shares of Auspex Pharmaceuticals, Inc. (NASDAQ:ASPX) closed at $72.90. Auspex Pharmaceuticals, Inc. on 16 March 2015, reported recent business highlights and announced its financial results for the three months and year ended December 31, 2014. For the three months ended December 31, 2014, Auspex reported a net loss of $20.0 million, an increase…
-
Morning Alert: Coronado Biosciences (NASDAQ:CNDO), Gilead Sciences Inc. (NASDAQ:GILD), J C Penney Company Inc (NYSE:JCP), Auspex Pharmaceuticals (NASDAQ:ASPX), ConocoPhillips (NYSE:COP)
On Tuesday shares of Coronado Biosciences, Inc. (NASDAQ:CNDO) closed at $4.28. Company’s EPS growth for next 5 years is recorded as 26.20%. Coronado Biosciences, Inc. (NASDAQ:CNDO) was up after it announced an exclusive worldwide license agreement with NeuPharma, Inc. to develop and commercialize novel irreversible and third generation epidermal growth factor receptor (EGFR) inhibitors outside…
-
Ever Green Stocks: Hydrogenics Corporation (NASDAQ:HYGS), MSB Financial Corp. (NASDAQ:MSBF), Auspex Pharmaceuticals (NASDAQ:ASPX), Zogenix (NASDAQ:ZGNX), China Lodging Group, Limited (NASDAQ:HTHT)
On March 4, Hydrogenics Corporation (NASDAQ:HYGS) reported fourth quarter and full year 2014 financial results. Results are reported in US dollars and are prepared in accordance with International Financial Reporting Standards (IFRS). On Tuesday shares of Hydrogenics Corporation (NASDAQ:HYGS) closed at $14.31. Company’s sales growth for last 5 years was 1.50% and EPS growth for…
-
Best Stocks: Rentech (NASDAQ:RTK), Freeport-McMoRan Inc. (NYSE:FCX), General Electric Company (NYSE:GE), Auspex Pharmaceuticals (NASDAQ:ASPX), Twitter Inc (NYSE:TWTR)
Rentech, Inc. (NASDAQ:RTK) announced that GSO Capital Partners LP (GSO), the credit investment arm of Blackstone, has increased its credit facility for Rentech by up to $63 million. The majority of the proceeds from this new facility are expected to fund completion of Rentech’s Canadian wood pellet projects through positive cash flow. Rentech now estimates…
-
Why Investors Are Watching: Auspex Pharmaceuticals (NASDAQ:ASPX), Swift Energy Co. (NYSE:SFY), National CineMedia (NASDAQ:NCMI), Tempur Sealy International (NYSE:TPX), DTE Energy (NYSE:DTE)
On 3 February, Auspex Pharmaceuticals Inc (NASDAQ:ASPX) announced that it has completed target enrollment in its pivotal clinical trial of SD-809 for the potential treatment of tardive dyskinesia (TD), called ARM-TD (Aim to Reduce Movement in TD).On Friday shares of Auspex Pharmaceuticals, Inc. (NASDAQ:ASPX) closed at $59.07. Swift Energy Company (NYSE: SFY) will report its…
-
Top Morning News: Advaxis (NASDAQ:ADXS), BlackBerry Ltd (NASDAQ:BBRY), Auspex Pharmaceuticals (NASDAQ:ASPX), Consumer Portfolio Services (NASDAQ:CPSS), Skullcandy (NASDAQ:SKUL)
Advaxis, Inc. (NASDAQ:ADXS), a clinical-stage biotechnology company developing cancer immunotherapies, announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application to conduct a Phase 1 clinical study of ADXS-HER2 (ADXS31-164) for the treatment of patients with metastatic HER2 expressing solid tumors. The clinical trial, which will be the…
-
Notable Moves: Five Prime Therapeutics (NASDAQ:FPRX), Auspex Pharmaceuticals (NASDAQ:ASPX), Digital Ally Inc. (NASDAQ:DGLY), Orange (NYSE:ORAN), Web.com Group (NASDAQ:WWWW)
On 12 January Five Prime Therapeutics, Inc. (NASDAQ:FPRX) announced the closing of its public offering of 3,829,944 shares of its common stock, which includes 419,994 shares sold upon the partial exercise of the underwriters’ option to purchase additional shares, resulting in aggregate gross proceeds of $84.3 million, before underwriting discounts and commissions, structuring fees and…
-
Investors Alert : Auspex Pharmaceuticals (NASDAQ:ASPX), Semtech Corporation (NASDAQ:SMTC), Pier 1 Imports (NYSE:PIR), LATAM Airlines Group S.A. (NYSE:LFL), ShoreTel (NASDAQ:SHOR)
On 12 January Auspex Pharmaceuticals, Inc. (NASDAQ:ASPX) announced that it has been developing SD-1077, a deuterium containing levodopa, in collaboration with Imphar AG, a private German-based drug development company, and it has entered into a share purchase agreement to acquire the remaining rights to SD-1077, and related intellectual property, through the acquisition of Imphar AG.…
-
Premarket Buzz: Apple Inc. (NASDAQ:AAPL), The Michaels Companies (NASDAQ:MIK), Auspex Pharmaceuticals (NASDAQ:ASPX), Facebook Inc (NASDAQ:FB), DreamWorks Animation SKG Inc. (NASDAQ:DWA)
Apple Inc’s (NASDAQ:AAPL) chief executive officer Tim Cook received a significant boost to his pay package after an “extraordinary year” that saw the company’s sales and operating income and share price rise. Cook received compensation valued at $9.22 million last year, more than double his$4.25-million in 2013. On Thursday shares of Apple Inc. (NASDAQ:AAPL) closed…
-
Big Movers: Whiting Petroleum Corp. (NYSE:WLL), Verizon Communications Inc. (NYSE:VZ), Qiwi plc (NASDAQ:QIWI), Umpqua Holdings Corporation (NASDAQ:UMPQ), Auspex Pharmaceuticals (NASDAQ:ASPX)
Effective January 1, 2015, each of the executive officers of Whiting Petroleum Corporation (NYSE:WLL) voluntarily agreed to terminate their Executive Excise Tax Gross-Up Agreement with the Company (the “Gross-Up Agreement”), which provided that if a change in control of the Company occurred, the Company would be obligated under certain circumstances to make a “gross-up” payment…